EW Healthcare Partners Mergers and Acquisitions Summary

Growth Capital Firm Profile

In the last 3 years, EW Healthcare Partners has invested in 2 companies.

EW Healthcare Partners’ most common sectors for investment aremedical products (42%) and life science (33%) . The Firm’s most common investment types include venture (56%) and growth capital (18%). In total, EW Healthcare Partners has invested in 17 US states and 8 different countries. Its largest (disclosed) acquisition occurred in 2004 when it acquired LipoSonix for $27M.

The Firm’s most common exit type is trade sale (66%). EW Healthcare Partners’ largest (disclosed) exit occurred in 2021 when it sold Cognate BioServices for $875M.

Join Mergr to view EW Healthcare Partners’ full profile and discover more large growth capital firm investors just like it.

M&A Summary

  • M&A Total Activity110
    • M&A Buy Activity58
    • M&A Sell Activity52
  • Total Sectors Invested 7
  • Total Countries Invested 8
  • M&A Buy/Sell Connections 58
  • M&A Advisors 4

EW Healthcare Partners

75 Rockefeller Plaza Suite 1700A,
New York, New York 10019
United States
(646) 429-1251
www.ewhealthcare.com
newyork@ewhealthcare.com

Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.


Investment Criteria

Sectors of Interest: Healthcare Services, Information Technology, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US, United Kingdom

Transaction Criteria Min Max
Target Revenue 20 200
Target EBITDA - -
Investment Size 20 80
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.6/yr) # 55 1 2 - - - 58
vol $42M $42M
Sell (0.6/yr) # 49 3 - - - - 52
vol $5.4B $875M $6.3B
  110

Most Recent M&A

Company Date Value Type
Germfree Laboratories, Inc. 2022-10-18 - Growth Capital
Ormond Beach, Florida · www.germfree.com
Grundium Oy 2022-05-05 - Stake Purchase
Tampere, Finland · www.grundium.com
Laboratoires Majorelle 2021-04-30 - Buyout (LBO, MBO, MBI)
Paris, France · www.laboratoires-majorelle.com
BreatheAmerica, Inc. 2021-03-12 - Add-on Acquisition
Nashville, Tennessee · www.breatheamerica.com
Cognate BioServices, Inc. 2021-02-17 875M USD Add-on Acquisition
Memphis, Tennessee · www.cognatebioservices.com
Bioventus LLC 2021-02-04 - IPO
Durham, North Carolina · www.bioventus.com
Cota, Inc. 2020-11-10 - Add-on Acquisition
New York, New Jersey · www.cotahealthcare.com
MiMedx Group, Inc. 2020-07-02 - Stake Purchase
Marietta, Georgia · www.mimedx.com
Symphogen AS 2020-06-04 - Add-on Acquisition
Ballerup, Denmark · www.symphogen.com
Venus Concept Ltd. 2019-11-08 - IPO
Toronto, Ontario · www.venusconcept.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Medical Products 4 (40%) - 24 (41%) 27M (64%)
Life Science 5 (50%) 15M (100%) 19 (33%) 15M (36%)
Healthcare Services - - 8 (14%) -
Information Technology - - 2 (3%) -
Internet Software and Services - - 2 (3%) -
Technology Hardware 1 (10%) - 2 (3%) -
Software - - 1 (2%) -
Total 10 $15M 58 $42M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 8 (80%) 15M (100%) 50 (86%) 42M (100%)
  California 3 (30%) - 20 (34%) 27M (64%)
  Pennsylvania - - 5 (9%) -
  North Carolina 1 (10%) 15M (100%) 3 (5%) 15M (36%)
  Florida 2 (20%) - 2 (3%) -
  Texas 1 (10%) - 2 (3%) -
  Georgia 1 (10%) - 2 (3%) -
  Washington - - 2 (3%) -
  Tennessee - - 2 (3%) -
  New Jersey - - 2 (3%) -
  Massachusetts - - 2 (3%) -
  Illinois - - 2 (3%) -
  New York - - 1 (2%) -
  Minnesota - - 1 (2%) -
  Michigan - - 1 (2%) -
  Maryland - - 1 (2%) -
  Kentucky - - 1 (2%) -
  Alabama - - 1 (2%) -
United Kingdom - - 2 (3%) -
France 1 (10%) - 1 (2%) -
Finland 1 (10%) - 1 (2%) -
Canada - - 1 (2%) -
  Ontario - - 1 (2%) -
Denmark - - 1 (2%) -
Switzerland - - 1 (2%) -
Uruguay - - 1 (2%) -
Total 10 $15M 58 $42M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 3 (30%) - 32 (55%) 27M (64%)
Growth Capital 2 (20%) 15M (100%) 10 (17%) 15M (36%)
Buyout (LBO, MBO, MBI) 1 (10%) - 7 (12%) -
Stake Purchase 3 (30%) - 5 (9%) -
PIPE 1 (10%) - 2 (3%) -
Recapitalization - - 1 (2%) -
Secondary Buyout - - 1 (2%) -
Total 10 $15M 58 $42M

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 22 (42%) 4.6B (72%)
Trade Sale 13 (25%) 1.8B (28%)
IPO 12 (23%) -
Merger 3 (6%) -
Secondary Sale 2 (4%) -
Total 52 $6.3B

Top M&A Advisors

Financial Deals
PwC Corporate Finance LLC
 3
Legal Deals
Kirkland & Ellis
 4
Reed Smith LLP
 2
Perkins Coie LLP
 1

Deal Values

buy # Total
< $100M 2 $42M
TOTAL $42M
Largest LipoSonix, Inc.
$27M (2004-07-11)
sell # Total
$100M to $1B 18 $6.1B
< $100M 4 $260M
TOTAL $6.3B
Largest Cognate BioServices, Inc.
$875M (2021-02-17)

M&A Connections

Deals
Acquired from
Investor(s)
3%
2 (3%)
Exited to
Investor(s)
4%
2 (4%)
Strategic(s)
71%
37 (71%)

Investor Summary

Investor Type

Growth Capital Firm

Size

Large

PE Assets

3.0B USD

Established

1985

Specialist/Generalist

Specialist

Leadership

Marty Sutter

Co-Founder & Managing Director

Richard Kolodziejcyk

CFO & CCO

Brooks Andrews

Managing Director

Evis Hursever

Managing Director

Petri Vainio

Managing Director

 Subscribe to unlock this and 193,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 184K M&A Transactions
  • 189K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 72K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal